Source: International Congress 2016 – Exploring mechanisms in health and disease
Disease area: Airway diseases



Rating:

Share or cite this content

Citations should be made in the following way:
Stefan Palme (Penzberg, Germany), Stefan Palme, Robert H. Christenson, Saeed A. Jortani, Richard E. Ostlund, Ruediger Kolm, Guido Kopal, Ruediger P. Laubender. Performance characteristics of an ECL immunoassay for the quantitation of serum periostin. Eur Respir J 2016; 48: Suppl. 60, 3448

Member's Comments

No comment yet.

Related content which might interest you: A novel, automated periostin assay; correlation with a commercial ELISA method and usability as an asthma biomarker Source: International Congress 2016 – Clinical and molecular studies in asthma Year: 2016 Performance evaluation of a novel point-of-care total IgE assay system in atopic patients Source: International Congress 2016 – Laboratory tests and cell biology in allergy and immunology Year: 2016 A new investigational use only automated immunoassay for periostin Source: International Congress 2015 – Novel strategies for the management of asthma, COPD and airway infections Year: 2015 Diagnostic accuracy of markers for detection of airway eosinophilia in asthma: A systematic review Source: International Congress 2014 – Airway biomarkers Year: 2014 Usefulness of periostin as a biomarker of pediatric asthma Source: International Congress 2015 – Paediatric asthma and allergy: lung function and biomarkers Year: 2015 Dialysis plus ultrafiltration significantly improves the detection of cytokines in induced sputum Source: Annual Congress 2013 –Systemic and airway biomarkers in respiratory diseases Year: 2013 Evaluation of inflammatory markers IL-6 and MMP-9 in asthma Source: International Congress 2015 – Clincal aspects of asthma: monitoring and mechanisms Year: 2015 Sputum interleukin (IL)-13 as a biomarker for the evaluation of asthma control Source: International Congress 2014 – Airway biomarkers Year: 2014 Novel proteomic biomarkers in the evaluation of childhood asthma Source: Annual Congress 2013 –Monitoring asthma: genes, cells and molecules Year: 2013 A scoring algorithm for predicting the presence of adult asthma Source: Annual Congress 2013 –Lung function tests to monitor airway diseases Year: 2013 U-BIOPRED asthma cohort: Inflammatory markers and corticosteroid use Source: Annual Congress 2013 –Novel mechanisms for established drugs for asthma and COPD management Year: 2013 Sputum YKL-40 is a potential biomarker of COPD-asthma overlap Source: International Congress 2014 – Systemic and airway biomarkers Year: 2014 Assessment of serum magnesium level in patients with bronchial asthma Source: International Congress 2016 – Systemic biomarkers Year: 2016 Routine serum protein electrophoresis and detection of alpha1-antitrypsin deficiency Source: Annual Congress 2013 –Diagnosis and management of respiratory diseases Year: 2013 Refined severity assessment of asthmatic children using molecular allergy diagnostics Source: Annual Congress 2013 –Uncontrolled and severe asthma in children Year: 2013 Reactive oxygen metabolite levels are surrogate biomarkers for predicting exacerbation of bronchial asthma Source: International Congress 2016 – Systemic biomarkers Year: 2016 COPD and the asthma-COPD-overlap-syndrome Source: International Congress 2014 – Asthma or COPD: comorbid condition or a poorly understood single disease? Year: 2014 Relation of plasma osteopontin levels with the clinical course in patients with COPD Source: International Congress 2014 – Systemic and airway biomarkers Year: 2014 Clustering analysis of clinical variables in U-BIOPRED adult asthma cohort Source: International Congress 2014 – Asthma: still a heterogeneous condition! Year: 2014 Asthma control index in European countries: The LIAISON (InternationaL cross-sectIonAl and longitudinal assessment on aSthma cONtrol) study cross-sectional results Source: International Congress 2014 – Phenotyping and monitoring asthma and COPD Year: 2014